<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty patients with distal <z:hpo ids='HP_0002583'>colitis</z:hpo> (<z:e sem="disease" ids="C0033252" disease_type="Disease or Syndrome" abbrv="">proctosigmoiditis</z:e>) in relapse were randonly allocated to twice daily treatment with traditional aqueous hydrocotrisone enemas (Cortenemas) or a suspension of <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> in an inert foam base (Colifoam) </plain></SENT>
<SENT sid="1" pm="."><plain>Each treatment contained the same amount of <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical, sigmoidoscopic, and histological response was assessed after two weeks </plain></SENT>
<SENT sid="3" pm="."><plain>Both agents were effective, and broadly similar in terms of objective improvement, but subjective improvement was greater with the foam preparation, and several patients expressed a preference to this mode of treatment </plain></SENT>
</text></document>